Home LiteratureArticle Details
PMID: 11751495 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL

Abstract

Beta-catenin is involved in homotypic cell-cell adhesion and the wnt signaling pathway. Deregulation of beta-catenin levels, caused in part by mutations of the adenomatous polyposis coli gene, is thought to play a role in the development of colorectal and other cancers. To further elucidate their roles, the expression pattern of beta-catenin and phosphospecific beta-catenin was correlated with clinical outcome in a series of patients with colorectal cancer. Immunohistochemical analysis of a tissue microarray with 650 colorectal cancer specimens was performed to study the expression and subcellular localization of beta-catenin and phosphospecific beta-catenin. These results were correlated with other clinicopathological factors and with overall survival. The majority of cancers retained some degree of beta-catenin membranous staining, whereas cytoplasmic or nuclear expression was seen in 42.5% and 20.4% of specimens, respectively. Phospho-beta-catenin showed nuclear staining in 9.5% of specimens, and there was no apparent membranous or cytoplasmic staining. There was no significant association between beta-catenin or phospho-beta-catenin and grade or stage. However, there was a positive correlation between beta-catenin and phospho-beta-catenin (P = 0.039), with phospho-beta-catenin representing a subset of nuclear beta-catenin. Patients with nuclear expression of beta-catenin did not have an altered survival compared with those that did not (P = 0.5611). Nuclear expression of phospho-beta-catenin, however, was associated with an improved survival (P = 0.0006). In multivariate analysis, only stage and phospho-beta-catenin were independently predictive of overall survival (P < 0.001 and P = 0.0034, respectively). These findings support a role for beta-catenin overexpression in colorectal tumorigenesis and provide initial evidence that phospho-beta-catenin may be a marker for improved overall survival independent of stage and grade.

MeSH Terms
Animals Cadherins/analysis Cell Line Cell Nucleus/pathology Colorectal Neoplasms/genetics,mortality,pathology Cytoplasm/pathology Cytoskeletal Proteins/analysis,genetics Dogs Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Neoplasm Staging Oligonucleotide Array Sequence Analysis Phosphoproteins/analysis Prognosis Proportional Hazards Models Recombinant Proteins/analysis Reproducibility of Results Survival Rate Trans-Activators Transfection Treatment Outcome beta Catenin
Chemicals
CTNNB1 protein, human Cadherins Cytoskeletal Proteins Phosphoproteins Recombinant Proteins Trans-Activators beta Catenin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Chung G G
Department of Internal Medicine, Section Medical Oncology, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06510, USA.
Provost E
Kielhorn E P
Charette L A
Smith B L
Rimm D L
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
Published
2001-12-00
Pages
4013-20
Language
English
Region
United States
NLM ID
9502500
Subset
IM
Grants
NIGMS NIH HHS · R01 GM 57604 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com